You finally have investor interest. Not vague encouragement, not “keep me posted,” but actual checks on the table. Then comes the question that trips up more first-time founders than almost anything else this early: Should we do a convertible note or a SAFE? Everyone seems to have a strong opinion. Twitter says SAFEs are founder-friendly. An angel says notes are “more real.” Your lawyer says, “It depends.” Meanwhile, you just want to close the round and get back to building.
To write this, we reviewed YC guidance, founder letters, early-stage financing docs, and public commentary from operators and investors who have actually used these instruments across multiple market cycles. We cross-checked how notes and SAFEs performed in practice during 2020–2024, especially in tighter fundraising environments, and focused on what broke, what caused friction, and what founders wish they had understood earlier.
In this article, we’ll walk through how convertible notes and SAFEs actually work, how the tradeoffs have shifted going into 2025, and how to decide which one fits your situation, not startup Twitter’s.
The Context Founders Are Operating In for 2025
Fundraising in 2025 is neither the free-money environment of 2021 nor the total freeze of late 2022. Capital is available, but it is more selective, more price-sensitive, and more documentation-aware. Early-stage investors still like speed, but they also care more about downside protection and clarity than they did a few years ago.
This matters because both SAFEs and convertible notes were designed to optimize for speed and simplicity. The difference is where that simplicity lives and who carries the risk if things go sideways.
If you get this choice wrong, the consequences usually don’t show up immediately. They surface 12–24 months later during a priced round, an extension, or a shutdown, when stress is already high.
What a Convertible Note Actually Is
A convertible note is debt. It accrues interest, has a maturity date, and converts into equity later, usually at your next priced round, with a discount, a valuation cap, or both.
In practice, early-stage founders almost never expect to repay the note in cash. Conversion is the plan. But the existence of a maturity date and repayment obligation changes the power dynamics.
Historically, many experienced angels preferred notes because they are familiar, enforceable, and clearly defined. If a company stalls, the note technically becomes payable, which gives investors leverage in renegotiations.
For founders, this can be either a forcing function or a liability.
What a SAFE Actually Is
A SAFE, or Simple Agreement for Future Equity, is not debt. It has no interest, no maturity date, and no repayment obligation. It converts into equity when a triggering event occurs, usually a priced equity round.
Y Combinator introduced SAFEs to remove friction and reduce founder stress around early fundraising. The intent was to let companies focus on growth instead of looming deadlines.
Over the past decade, SAFEs have become the default instrument for pre-seed rounds, especially in the US. By 2021, many founders had never even seen a convertible note.
That popularity is exactly why the tradeoffs matter more now.
The Core Tradeoffs, Without the Marketing Spin
Here is the cleanest way to think about the difference.
Convertible notes optimize for investor protection.
SAFEs optimize for founder flexibility.
Neither is inherently better. They are tools.
A note gives investors leverage through time and interest. A SAFE gives founders runway without contractual pressure. The problem arises when the instrument does not match the company’s trajectory.
How These Instruments Behave When Things Go Well
When your company raises a priced round quickly, both SAFEs and notes usually convert cleanly. The differences barely matter.
This is why many founders underestimate the decision. In success scenarios, almost everything works.
If you raise a Series A within 12–18 months:
- Notes convert, interest is negligible.
- SAFEs convert, paperwork is clean.
- No one complains.
The choice only becomes meaningful in non-ideal paths.
How They Behave When Things Take Longer Than Planned
This is where 2025 realities matter.
With a convertible note, a slow timeline triggers the maturity date. Even if investors are friendly, you are forced into a conversation: extend, convert early, or repay. That conversation happens when your leverage is weakest.
Some founders appreciate this pressure because it forces discipline. Others find it destabilizing, especially if different note holders want different outcomes.
With a SAFE, there is no deadline. That sounds great until you realize that investors also have no forcing mechanism. If progress is slow, you may accumulate multiple SAFEs at different caps, creating a messy cap table that scares off later investors.
In the past two years, many seed investors quietly started pushing back on over-stacked SAFEs precisely because of this dynamic.
Valuation Caps Are Doing More Work Than You Think
In 2025, the real negotiation is rarely about note vs SAFE. It is about the valuation cap.
A SAFE with a low cap can be more founder-unfriendly than a note with a reasonable cap and discount. Conversely, a note with a short maturity and aggressive cap can be worse than a clean SAFE.
Founders often focus on the label and ignore the economics. That is a mistake.
What matters is:
- How much dilution are you implicitly locking in?
- How much leverage do investors have if timelines slip?
- How complex your cap table becomes before a priced round.
Investor Signaling Has Shifted
One subtle but important change going into 2025: some institutional seed funds now see excessive SAFE stacking as a negative signal.
This does not mean SAFEs are bad. It means that using them indefinitely, without a plan to price the company, can look like avoidance rather than strategy.
Convertible notes, by contrast, signal an expectation of a defined next step, even if it is flexible in practice.
This signaling effect should not dominate your decision, but it should be acknowledged.
A Simple Decision Framework for Founders
Use a SAFE if:
- You are raising a true pre-seed.
- The round is small and fast.
- You expect to raise a priced round within 12–18 months.
- You want to minimize legal overhead and pressure.
Use a convertible note if:
- You are raising a larger seed round.
- Investors are writing meaningful checks.
- You want clearer alignment around timing.
- You are comfortable with a maturity-driven forcing function.
If you are somewhere in the middle, the right answer is often a SAFE with disciplined caps and a clear internal timeline to price the company.
Common Founder Mistakes to Avoid
One, assuming SAFEs are “free” because they are simple.
They are not. They defer complexity; they do not eliminate it.
Two, mixing too many instruments.
Multiple SAFEs, plus a note, almost always create unnecessary friction later.
Three, optimizing for speed without modeling dilution.
Fast money can be expensive money.
Four, ignoring how this round sets a precedent.
Early terms tend to repeat.
Do This Week
- Model dilution under both a SAFE and a note using realistic future valuations.
- Decide on your target timeline for a priced round before choosing an instrument.
- Limit yourself to one instrument type in this round.
- Be intentional about valuation caps, not just the headline structure.
- Ask at least one investor how they’ve seen this instrument break.
- Pressure-test your cap table with a hypothetical slow-growth scenario.
- Align co-founders on risk tolerance around timing and leverage.
- Choose the instrument that matches your actual plan, not your optimism.
Final Thoughts
Convertible notes and SAFEs are not moral choices or identity statements. They are risk-allocation tools. In 2025, the right choice depends less on what is fashionable and more on how honest you are about your timeline, leverage, and appetite for pressure. Pick the instrument that lets you focus on building real traction without creating a future mess you will regret cleaning up later.
Photo by Austin Distel; Unsplash
